Silgan Holdings declares quarterly dividend of $0.20 per share

Published 05/08/2025, 21:46
Silgan Holdings declares quarterly dividend of $0.20 per share

NORWALK, Conn. - Silgan Holdings Inc. (NYSE:SLGN), with a market capitalization of approximately $5 billion, announced Tuesday that its Board of Directors has declared a quarterly cash dividend of $0.20 per share on its common stock, representing a 1.75% yield.

The dividend will be payable on September 16, 2025, to shareholders of record as of September 2, 2025, according to a press release statement from the company.

With this payment, Silgan will have paid quarterly cash dividends for 86 consecutive quarters since 2004, maintaining its track record of increasing its dividend annually during this period.

Silgan Holdings, which reported annual net sales of approximately $5.9 billion in 2024, is a supplier of rigid packaging solutions. The company operates 124 manufacturing facilities across North and South America, Europe, and Asia.

The company provides dispensing and specialty closures for various consumer products including fragrance, food, beverage, and personal care items. Silgan also supplies metal containers in North America and Europe for pet and human food products, as well as custom containers for shelf-stable food and personal care products in North America.

In other recent news, Silgan Holdings Inc. reported its Q2 2025 earnings, which revealed an adjusted earnings per share (EPS) of $1.01, slightly below the anticipated $1.03. Despite this earnings miss, the company’s revenue exceeded expectations, coming in at $1.54 billion compared to the forecasted $1.53 billion. These financial results represent the latest developments for Silgan Holdings. The earnings report highlights the company’s ability to surpass revenue projections, even as the EPS fell short of analyst estimates. This performance comes amid broader market reactions and investor concerns. The discrepancy between earnings and revenue outcomes provides insight into the company’s financial health. While the earnings miss might have influenced market sentiment, the revenue beat is a noteworthy aspect of Silgan Holdings’ recent financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.